Article
The Prognostic Value and Function of HOXB5 in Acute Myeloid Leukemia
5 Aug 2021
Abstract excerpt
Background Currently, cytogenetic and genetic markers are the most important for risk stratification and treatment of patients with acute myeloid leukemia (AML). Despite the identification of many prognostic factors, relatively few have made their way into clinical practice. Therefore, the identification of new AML biomarkers is useful in the prognosis and monitoring of AML and contributes to a better...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
